Noncanonical amino acid incorporation enables minimally disruptive labeling of stress granule and TDP-43 proteinopathy

This study demonstrates that integrating genetic code expansion with rational site selection allows for the minimally disruptive incorporation of the fluorescent noncanonical amino acid Anap into G3BP1 and TDP-43, enabling highly accurate visualization of their stress-induced dynamics and pathobiology in live cells and neurons without compromising protein function.

The Gist

Imagine you are trying to watch a busy construction site (a living cell) to see how workers (proteins) build and repair things. For decades, scientists have tried to track these workers by gluing a giant, bright neon sign onto their backs. The problem? The sign is so heavy and bulky that it changes how the worker moves, makes them clumsy, and sometimes even stops them from doing their job. You end up watching a "neon worker" that doesn't act like a real worker at all.

This paper introduces a clever new trick to watch these workers without messing up their job. Here is the story in simple terms:

The Problem: The "Neon Backpack"

The proteins the scientists wanted to study are G3BP1 and TDP-43.

• G3BP1 is like a foreman who organizes emergency response teams (called "stress granules") when the cell is under attack.
• TDP-43 is a librarian who manages the cell's instruction manuals (RNA). When things go wrong, TDP-43 can get stuck in the wrong place, leading to diseases like ALS (Lou Gehrig's disease).

To see them, scientists usually attach a big, glowing protein (like GFP) to them. But this "neon backpack" is too heavy. It changes the worker's behavior, making it hard to tell if what you see is the real worker or just the effect of the backpack.

The Solution: The "Invisible Tattoo"

The researchers used a technique called Genetic Code Expansion. Think of the cell's DNA as a recipe book written in a language of three-letter words (codons). Usually, one of these words, "TAG," means "Stop cooking here."

The scientists did two things:

1. The Secret Ingredient: They introduced a tiny, glowing amino acid called Anap. It's not a giant backpack; it's more like a tiny, glowing tattoo ink. It's so small it barely takes up any space.
2. The Translator: They gave the cell a special "translator" (an enzyme and a tRNA) that ignores the "Stop" sign. Instead of stopping, the translator swaps the "TAG" word for the glowing Anap ingredient.

So, instead of gluing a backpack on, they simply replaced one single letter in the protein's recipe with a glowing letter. The protein is now glowing, but it's still the same size and shape as the original.

What They Discovered

They tested this on G3BP1 and TDP-43 in human cells and even in mouse brain cells (neurons).

1. The Foreman (G3BP1) Moves Freely
When the cell was stressed, G3BP1 rushed to form emergency teams (stress granules).

• With the old method (GFP): The "neon backpack" made the foreman sluggish. He moved slowly and didn't recover well after the stress passed.
• With the new method (Anap): The foreman moved quickly and naturally. He formed teams and dissolved them just like a real foreman would. The scientists could see the "liquid" nature of these teams, which was hidden before.

2. The Librarian (TDP-43) Stays in the Right Place
Normally, TDP-43 lives in the cell's nucleus (the office). In disease, it gets stuck in the cytoplasm (the factory floor) and forms hard, solid clumps.

• With the old method (YFP): The heavy tag forced the librarian to stay in the nucleus and form weird clumps there, even when he shouldn't have. It gave a false picture of the disease.
• With the new method (Anap): The librarian stayed in the office until stress hit, then naturally moved to the factory floor. The clumps he formed were "liquid-like" (fluid), not solid. This is a crucial detail because it suggests the disease might start with fluid clumps that harden later, a nuance the old method missed.

3. The Workers Still Do Their Jobs
The most important test: Did the glowing tattoo break the workers?

• They removed the natural TDP-43 from cells (which usually kills the cell).
• They added the "Anap-tattooed" TDP-43 back in.
• Result: The cells survived and worked perfectly! The tattooed librarian could still read the manuals and keep the cell alive. This proves the method is safe and doesn't break the protein's function.

Why This Matters

This paper is like upgrading from a clumsy, heavy camera to a tiny, high-speed drone.

• Before: We were watching a distorted version of these proteins, leading to confusion about how diseases like ALS work.
• Now: We can watch the proteins in their natural state, in real-time, inside living brain cells.

By seeing the proteins move and behave exactly as they do in nature, scientists can finally understand the early steps of neurodegenerative diseases. This could lead to better treatments that stop the disease before the "liquid clumps" turn into the "solid blocks" that kill brain cells.

In short: They found a way to paint a protein with a single drop of glowing paint instead of strapping a neon sign to it, allowing us to see the true, natural dance of life and disease.

Technical Summary

1. Problem Statement

Conventional methods for live-cell protein imaging rely on large fluorescent protein tags (e.g., GFP, YFP) or small-molecule binding motifs fused to the N- or C-termini of target proteins. While useful, these approaches have significant limitations:

• Structural and Functional Perturbation: Large tags can alter protein folding, stability, localization, and phase separation dynamics.
• Artifactual Behavior: For proteins like TDP-43, conventional tagging often requires deleting the Nuclear Localization Signal (NLS) to force cytoplasmic aggregation, creating non-physiological conditions that obscure native trafficking and aggregation mechanisms.
• Limited Resolution: Large tags may interfere with the formation of membraneless organelles (like stress granules) or mask critical interaction domains.

There is a critical need for a labeling strategy that is minimally disruptive, site-specific, and capable of preserving the native biophysical properties of proteins involved in neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).

2. Methodology

The authors developed a labeling platform based on Genetic Code Expansion (GCE) using the fluorescent noncanonical amino acid (ncAA) Anap (3-(6-acetylnaphthalen-2-ylamino)-2-aminopropanoic acid).

• Target Proteins:
  • G3BP1: A core component of stress granules.
  • TDP-43: A protein linked to ALS/FTD pathology, known for cytoplasmic mislocalization and aggregation.
• Site Selection Strategy:
  • Rational selection of amber codon (TAG) insertion sites based on structural and functional criteria.
  • G3BP1: F337TAG (selected to avoid functional domains, RNA binding sites, and localization signals).
  • TDP-43: V100TAG (selected to avoid major functional domains and aggregation-prone regions).
  • Sites were chosen to be solvent-accessible and structurally tolerant, avoiding highly conserved residues.
• Experimental System:
  • GCE System: Co-expression of an orthogonal tRNA/synthetase pair (pAnap plasmid) and the TAG-mutated protein plasmid in mammalian cells (HeLa, U2OS, mouse ES cells) and primary mouse cortical neurons.
  • Labeling: Incorporation of Anap requires the addition of exogenous Anap to the culture medium.
  • Controls: Rigorous controls were performed to ensure signal specificity (e.g., no fluorescence without Anap, no fluorescence without the TAG mutation).
• Assays Performed:
  • Immunofluorescence: Comparison of Anap signals with antibody staining.
  • FRAP (Fluorescence Recovery After Photobleaching): To measure protein mobility and liquid-like vs. solid-like dynamics within condensates.
  • Functional Rescue Assays: Testing cell viability in TDP-43 knockout models and RNA splicing activity (PFKP cryptic exon inclusion).
  • Stress Induction: Treatment with sodium arsenite to induce stress granule formation and TDP-43 mislocalization.

3. Key Contributions

• Development of a Minimally Disruptive Platform: Successfully adapted GCE for two critical neurodegenerative disease proteins, demonstrating that a single-residue substitution with Anap preserves native protein architecture better than large fusion tags.
• Discovery of Hidden Protein Pools: The Anap labeling revealed nuclear pools of G3BP1 that were undetectable by conventional antibody staining, suggesting limitations in current antibody-based detection methods.
• Validation of Native Dynamics: Demonstrated that Anap-labeled proteins exhibit "liquid-like" dynamics in stress granules and cytoplasmic inclusions, whereas large-tagged versions (GFP/YFP) often showed impaired mobility or aberrant localization (e.g., nuclear puncta in TDP-43-YFP).
• Functional Preservation: Proved that Anap incorporation does not compromise the biological function of TDP-43, as it could rescue cell death and restore RNA splicing activity in TDP-43-deficient cells.

4. Key Results

A. G3BP1 Labeling and Stress Granule Dynamics

• Localization: Under basal conditions, G3BP1-Anap showed diffuse cytoplasmic localization and a distinct nuclear signal not seen with antibodies. Upon stress (sodium arsenite), it rapidly assembled into stress granules, colocalizing perfectly with TIA-1 and antibody staining.
• Mobility (FRAP): G3BP1-Anap exhibited significantly higher fluorescence recovery (53%) compared to G3BP1-GFP (33%). This indicates that the Anap tag imposes less steric hindrance, allowing for more native, rapid exchange within stress granules.

B. TDP-43 Labeling and Pathology

• Localization: TDP-43-Anap remained predominantly nuclear under basal conditions, matching antibody staining. Upon stress, it mislocalized to cytoplasmic inclusions.
• Comparison with Tags:
  • TDP-43-YFP: Failed to recapitulate cytoplasmic mislocalization; instead, it formed prominent nuclear puncta under stress, suggesting the YFP tag distorted native trafficking.
  • TDP-43-ΔNLS-YFP: While this forced cytoplasmic localization, it formed solid-like aggregates with low mobility (~22% FRAP recovery).
  • TDP-43-Anap: Showed cytoplasmic mislocalization similar to wild-type behavior and exhibited liquid-like dynamics (~45% FRAP recovery), suggesting the inclusions were less rigid than those formed by the NLS-deleted YFP construct.
• Functional Rescue:
  • In TDP-43 knockout HeLa and mouse ES cells, TDP-43-Anap fully rescued cell viability under oxidative stress, comparable to wild-type TDP-43 overexpression.
  • It restored the splicing of the PFKP gene (a known TDP-43 target), confirming that the ncAA incorporation did not disrupt RNA-binding or splicing functions.

C. Neuronal Application

• The system was successfully applied to primary mouse cortical neurons.
• Anap labeling faithfully recapitulated the localization and stress-induced redistribution of both G3BP1 and TDP-43 in a neuronal environment, a critical setting for ALS/FTD research where conventional tagging often fails due to toxicity or mislocalization.

5. Significance

• Physiological Relevance: This study provides a robust, genetically encoded tool to study ALS/FTD proteinopathies without the artifacts introduced by large fluorescent tags. It allows researchers to observe "early events" in disease progression (e.g., stress granule maturation, initial mislocalization) with high fidelity.
• Mechanistic Insight: The findings suggest that TDP-43 cytoplasmic inclusions formed under stress may possess more liquid-like properties than previously thought (based on ΔNLS-YFP models), which has implications for understanding the transition from reversible stress granules to pathological aggregates.
• Generalizability: The strategy offers a blueprint for labeling other disease-relevant proteins where structural integrity and native dynamics are paramount, bridging the gap between structural biology and live-cell functional imaging.

In conclusion, the authors demonstrate that Anap-based GCE is superior to conventional tagging for studying the dynamic behavior of G3BP1 and TDP-43, offering a minimally invasive window into the molecular mechanisms of neurodegeneration.